Evidence map›Paper›PMID 35011520›Full record

ReviewMolecules (Basel, Switzerland)2022

Nanostructured Lipid Carriers-Hydrogels System for Drug Delivery: Nanohybrid Technology Perspective.

Sharifah Nurfadhlin Afifah Syed Azhar, Siti Efliza Ashari, Norhazlin Zainuddin, Masriana Hassan

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Control of a Gel-Forming Chemical Reaction Network Using Light-Triggered Proton Pumps.Langmuir : the ACS journal of surfaces and colloids · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sharifah Nurfadhlin Afifah Syed AzharIntegrated Chemical BioPhysics Research Centre (iCheBP), Faculty of Science, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia.
Siti Efliza AshariIntegrated Chemical BioPhysics Research Centre (iCheBP), Faculty of Science, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia.ORCID 0000-0001-5425-2578
Norhazlin ZainuddinDepartment of Chemistry, Faculty of Science, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia.
Masriana HassanDepartment of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia.

Funding

Ministry of Higher Education FRGS/1/2020/WAB13/UPM/02/1
6 · The paper itself

Abstract

Advanced hybrid component development in nanotechnology provides superior functionality in the application of scientific knowledge for the drug delivery industry. The purpose of this paper is to review important nanohybrid perspectives in drug delivery between nanostructured lipid carriers (NLC) and hydrogel systems. The hybrid system may result in the enhancement of each component's synergistic properties in the mechanical strength of the hydrogel and concomitantly decrease aggregation of the NLC. The significant progress in nanostructured lipid carriers-hydrogels is reviewed here, with an emphasis on their preparation, potential applications, advantages, and underlying issues associated with these exciting materials.

Indexed as

Drug Delivery SystemsNanotechnologyAnimalsChemical PhenomenaDrug CarriersHumansLipidsNanogelsDrug CarriersLipidsNanogelsdrug deliveryhydrogelnanohybrid systemnanostructured lipid carriers

Identifiers

PMID35011520
PMCPMC8746478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.